Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 16, 2020
Evaluation and optimization of a clinical pharmacist driven transitions of care model for malignant hematologyLucas S Wind, Thomas G Knight, Jessica J Auten, et al.Clinical Lymphoma, Myeloma & Leukemia|November 5, 2017
A Comparison of Clofarabine-based (GCLAC) and Cladribine-based (CLAG) Salvage Chemotherapy for Relapsed/Refractory AMLBenyam Muluneh, Kaitlyn Buhlinger, Allison M Deal, et al.Pathogens & Immunity|December 23, 2016
Increasing Rates of Fluoroquinolone Resistance in Escherichia coli Isolated From the Blood and Urine of Patients with Hematologic Malignancies and Stem Cell Transplant RecipientsChristopher G Hauck, Pearlie P Chong, Melissa B Miller, et al.Haematologica|July 21, 2022
Time spent at home among older adults with acute myeloid leukemia receiving azacitidine- or venetoclax-based regimensChristopher E Jensen, Hilary M Heiling, Konan E Beke, et al.Leukemia & Lymphoma|December 14, 2011
A phase I dose-escalation study of clofarabine in combination with fractionated gemtuzumab ozogamicin in patients with refractory or relapsed acute myeloid leukemiaMatthew C Foster, Chirag Amin, Peter M Voorhees, et al.Blood Advances|September 28, 2021
Bilineal evolution of a U2AF1-mutated clone associated with acquisition of distinct secondary mutationsNathan D Montgomery, Jonathan Galeotti, Steven M Johnson, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 28, 2019
Patient engagement in first cycle comprehensive chemotherapy consultation pharmacist services and impact on patient activationJill S Bates, Jessica Auten, Margaret R Sketch, et al.Leukemia & Lymphoma|November 3, 2023
Comprehensive genomic profiling reveals molecular subsets of ASXL1-mutated myeloid neoplasmsSteven M Johnson, James Haberberger, Jonathan Galeotti, et al.The Annals of Pharmacotherapy|September 20, 2021
Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid LeukemiaAndy H Szeto, Tyler Bucci, Allison Deal, et al.British Journal of Haematology|July 23, 2016
A phase II trial of bendamustine in combination with rituximab in older patients with previously untreated diffuse large B-cell lymphomaSteven I Park, Natalie S Grover, Oludamilola Olajide, et al.Pageof 4